Search research articles
Contact Us
Filters
Showing results (81-90 of 97) with videos related to
Page
of 10
Sort By:
The Journal of Antimicrobial Chemotherapy
|
June 13, 2023
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
Jannik Stemler, Sibylle C Mellinghoff, Yascha Khodamoradi, et al.
Mycoses
|
August 12, 2018
Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO)
Markus Ruhnke, Gerhard Behre, Dieter Buchheidt, et al.
British Journal of Haematology
|
September 30, 2017
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial
Hermann Einsele, Monika Engelhardt, Christoph Tapprich, et al.
Antimicrobial Agents and Chemotherapy
|
June 7, 2017
Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia
Carlota Gudiol, Cristina Royo-Cebrecos, Edson Abdala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2019
Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group
Michael Fuchs, Helen Goergen, Carsten Kobe, et al.
Frontiers in Oncology
|
April 7, 2023
Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial
Susanne Wiegand, Gunnar Wichmann, Jeannette Vogt, et al.
Leukemia
|
August 30, 2019
Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis
Stefan Knop, Monika Engelhardt, Peter Liebisch, et al.
Cancers
|
April 3, 2021
Kinetics of Renal Function during Induction in Newly Diagnosed Multiple Myeloma: Results of Two Prospective Studies by the German Myeloma Study Group DSMM
Friederike Bachmann, Martin Schreder, Monika Engelhardt, et al.
The Lancet. Haematology
|
May 28, 2021
PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial
Stefanie Kreissl, Helen Goergen, Ina Buehnen, et al.
Lancet (London, England)
|
October 25, 2017
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group
Peter Borchmann, Helen Goergen, Carsten Kobe, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 97) with videos related to
Sort By:
Page
of 10
The Journal of Antimicrobial Chemotherapy
|
June 13, 2023
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
Jannik Stemler, Sibylle C Mellinghoff, Yascha Khodamoradi, et al.
Mycoses
|
August 12, 2018
Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO)
Markus Ruhnke, Gerhard Behre, Dieter Buchheidt, et al.
British Journal of Haematology
|
September 30, 2017
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial
Hermann Einsele, Monika Engelhardt, Christoph Tapprich, et al.
Antimicrobial Agents and Chemotherapy
|
June 7, 2017
Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia
Carlota Gudiol, Cristina Royo-Cebrecos, Edson Abdala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2019
Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group
Michael Fuchs, Helen Goergen, Carsten Kobe, et al.
Frontiers in Oncology
|
April 7, 2023
Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial
Susanne Wiegand, Gunnar Wichmann, Jeannette Vogt, et al.
Leukemia
|
August 30, 2019
Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis
Stefan Knop, Monika Engelhardt, Peter Liebisch, et al.
Cancers
|
April 3, 2021
Kinetics of Renal Function during Induction in Newly Diagnosed Multiple Myeloma: Results of Two Prospective Studies by the German Myeloma Study Group DSMM
Friederike Bachmann, Martin Schreder, Monika Engelhardt, et al.
The Lancet. Haematology
|
May 28, 2021
PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial
Stefanie Kreissl, Helen Goergen, Ina Buehnen, et al.
Lancet (London, England)
|
October 25, 2017
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group
Peter Borchmann, Helen Goergen, Carsten Kobe, et al.
Page
of 10